Description
This assay uses the Luminex® 200™ platform.
Our featured assay wells are available in limited quantities, priced attractively for market testing. If we’re unable to fulfill your request, we’ll promptly inform you of the available quantity. We appreciate your understanding and interest in our offerings!
Signal for this assay is typically low end and a pilot is recommended to ensure compatibility.
Consider this assay for a comprehensive analysis of cardiovascular biomarkers in mouse models. The Mouse Cardiovascular Disease Panel 2 9-Plex Assay (MCVD2-09-107) measures CXCL16, Endocan-1, Light, Follistatin, Oncostatin M, sCD40L, PLGF-2, Troponin I, and Troponin II, providing valuable insights into cardiovascular health and disease.
Ideal for studying cardiovascular conditions such as heart failure, myocardial infarction, and vascular inflammation, this assay helps elucidate the roles of these biomarkers in disease mechanisms. For instance, Troponin I and Troponin II are critical for assessing myocardial injury, while CXCL16 and Endocan-1 are involved in vascular inflammation and endothelial function.
Discover the power of precision with our assay, expertly designed for the Luminex® 200™ platform. This cutting-edge technology enables the simultaneous detection of multiple biomarkers from a minimal single sample, delivering comprehensive insights with unmatched efficiency. Streamline your research and unlock a new level of detail with our advanced multiplex assay solution.
Click here for information on shipping biological samples for Discovery Assays